Phio Pharma Q2 EPS $(1.47) Up From $(2.28) YoY
Portfolio Pulse from Benzinga Newsdesk
Phio Pharma reported Q2 losses of $(1.47) per share, a 35.53% improvement from the $(2.28) per share loss reported in the same period last year.
August 10, 2023 | 8:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Phio Pharma's Q2 losses per share have improved by 35.53% compared to the same period last year.
Phio Pharma's Q2 earnings report shows a significant improvement in losses per share compared to the same period last year. This indicates a positive financial performance, which could potentially lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100